The direct effects of stored blood products may worsen prognosis of cancer patients; shall we transfuse or not? An explanation of the adverse oncological consequences of blood product transfusion with a testable hypothesis driven experimental research protocol

Medical Hypotheses

Volumn 71, Issue 4, 2008, Pages 489-492

  Upile, Tahwinder ^a,b,c   Jerjes, Waseem ^b,d,e   Sandison, Ann ^f   Singh, Sandeep ^b   Rhys Evans, Peter ^c   Sudhoff, Holger ^a   Hopper, Colin ^b,d,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c Royal Marsden Hospital   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR;

ARTICLE; BLOOD TRANSFUSION; CANCER PATIENT; CLINICAL PROTOCOL; HYPOTHESIS; LEUKOPENIA; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

BLOOD; BLOOD TRANSFUSION; HUMANS; MODELS, THEORETICAL; NEOPLASMS; PROGNOSIS;

EID: 50449092843     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.04.027     Document Type: Article

References (15)

1. Francis D., and Shenton B. Blood transfusion and tumour growth: evidence from laboratory animals. Lancet 2 8251 (1981) 871
2. McFarland J. Perioperative blood transfusions: indications and options. Chest 115 (1999) 113S-121S
3. Edvardsen L., Taaning E., Dreier B., Christensen L., Mynster T., and Nielsen H. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates. Am J Hematol 67 (2001) 157-162
4. Werther K., Christensen I., and Nielsen H. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest 62 (2002) 343-350
5. Chin-Yee I., Arya N., and d'Almeida M.S. The red cell storage lesion and its implication for transfusion. Transfus Sci 18 (1997) 447-458
6. Mynster T., Dybkjoer E., Kronborg G., and Nielsen H. Immunomodulating effect of blood transfusion: is storage time important?. Vox Sang 74 (1998) 176-181
7. Mynster T., and Nielsen H. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery Danish RANX05 Colorectal Cancer Study Group. Scand J Gastroenterol 35 (2000) 212-217
8. Mynster T. Effects of red cell storage and lysis on in vitro cytokine release. Transfus Apheresis Sci 25 (2001) 17-23
9. Offner P. Age of blood: does it make a difference?. Crit Care 8 (2004) S24-S26
10. Taniguchi Y., and Okura M. Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma. Head Neck 25 (2003) 931-936
11. Nielsen H., Werther K., Mynster T., and Brunner N. Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion 39 (1999) 1078-1083
12. Alitalo K.K. Vascular endothelial growth factors, multiple roles in cancer. Meniscus Educational Institute (2004) 1-24
13. Cunha G., and Matrisian L. It's not my fault, blame it on my microenvironment. Differentiation 70 (2002) 469-472
14. Ozawa C., Banfi A., Glazer N., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113 (2004) 516-527
15. Folberg R., Hendrix M., and Maniotis A. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156 (2000) 361-381